1123738-15-7 Usage
Description
3-Bromoquinolin-5-ol, a quinoline derivative with the molecular formula C9H6BrNO and a molecular weight of 225.05 g/mol, is a brominated derivative of quinolin-5-ol. This white to off-white powder has a melting point of 191-192°C and is known for its unique chemical properties, making it a promising candidate in organic synthesis and pharmaceutical research.
Uses
Used in Pharmaceutical Research and Development:
3-Bromoquinolin-5-ol is used as a building block in the development of medications and pharmaceutical products. Its unique chemical properties contribute to the creation of new compounds with potential therapeutic applications.
Used in Organic Synthesis:
3-Bromoquinolin-5-ol serves as a valuable reagent in the production of various organic compounds. Its versatility in chemical reactions allows for the synthesis of a wide range of organic molecules.
Used in Laboratory Settings:
3-Bromoquinolin-5-ol is widely utilized in laboratory settings for chemical reactions and synthesis processes. Its presence in research environments facilitates the exploration of new chemical pathways and the development of innovative synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 1123738-15-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,3,7,3 and 8 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1123738-15:
(9*1)+(8*1)+(7*2)+(6*3)+(5*7)+(4*3)+(3*8)+(2*1)+(1*5)=127
127 % 10 = 7
So 1123738-15-7 is a valid CAS Registry Number.
1123738-15-7Relevant articles and documents
Palladium-Catalyzed Carbonylation of (Hetero)Aryl, Alkenyl and Allyl Halides by Means of N-Hydroxysuccinimidyl Formate as CO Surrogate
Barré, Ana?s,T?nta?, Mihaela-Liliana,Alix, Florent,Gembus, Vincent,Papamica?l, Cyril,Levacher, Vincent
, p. 6537 - 6544 (2015)
An efficient Pd-catalyzed carbonylation protocol is described for the coupling of a large panel of aryl, heteroaryl, benzyl, vinyl and allyl halides 2 with the unusual N-hydroxysuccinimidyl (NHS) formate 1 as a CO surrogate to afford the corresponding valuable NHS esters 3. High conversion to the coupling products was achieved with up to 98% yield by means of Pd(OAc)2/Xantphos catalyst system.
Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase
Porter, John,Lumb, Simon,Lecomte, Fabien,Reuberson, James,Foley, Anne,Calmiano, Mark,le Riche, Kelly,Edwards, Helen,Delgado, Jean,Franklin, Richard J.,Gascon-Simorte, Jose M.,Maloney, Alison,Meier, Christoph,Batchelor, Mark
, p. 397 - 400 (2011/03/17)
A series of quinoxaline inhibitors of c-Met kinase is described. The postulated binding mode was confirmed by an X-ray crystal structure and optimisation of the series was performed on the basis of this structure. Future directions for development of the